Abstract. B7-H3 belongs to the B7 superfamily, a group of molecules that costimulate or downmodulate T cell responses. Although it has been shown that B7-H3 can inhibit T cell responses, several studies, most of them performed in murine systems, found B7-H3 to act in a co-stimulatory manner. In addition, B7-H3 is also expressed in various human cancers and is correlated with the poor outcome of cancer patients. The functional role of B7-H3 in cancer is still controversially discussed. In the present study, we compared B7-H3 expression in normal gastric tissues and gastric cancer tissue specimens and determined the effects of low B7-H3 expression on the human gastric cancer cell line SGC-7901 by using RNAi. B7-H3 expression in gastric specimens was determined by tissue qPCR and immunohistochemisty. A SGC-7901 cell line with low B7-H3 expression was established by lentiviralmediated RNA interference to investigate the effect of B7-H3 on cancer cell migration and invasion in vitro. By establishing an orthotopic transplantation gastric cancer mouse model, the effect of B7-H3 on cell migration and invasion was studied in vivo. B7-H3 expression was significantly higher in the gastric cancer group than that in the normal gaster group. B7-H3 knockdown by RNA interference decreased cell migration and Transwell invasion up to 50% in vitro. In the orthotopic transplantation gastric cancer mouse model, the effect of inhibiting metastasis by knockdown of B7-H3 was assessed in terms of the average postmortem abdominal visceral metastatic tumor weight. The results revealed that inhibition of B7-H3 expression reduced gastric cancer metastasis in vivo. In conclusion, B7-H3 is aberrantly expressed in gastric cancer. In addition to modulating tumor immunity, B7-H3 may have a novel role in regulating SGC-7901 cell metastasis.
Introduction
Gastric cancer is the fourth most common cancer and the second leading cause of cancer-related death in the world (1) . Recent improvements in diagnostic techniques and perioperative management have resulted in an increase in the early detection of gastric cancer and a decrease in its mortality in the past decades. Surgery is an effec tive treatment for gastric cancer if the disease is diagnosed at an early stage, whereas cases of inoperable or metastatic disease are not curable. Several factors seem to restrict diagnostic and therapeutic strategies for the treatment of gastric cancer and consequently, to incur an insufficient survival rate: i) a lack of satisfactory diagnostic assays for early detection of gastric cancer; ii) an absence of valuable prognostic indicators; iii) the insufficient effectiveness of present treatments including surgery, chemotherapy immunotherapy and biotherapy for gastric cancer patients with advanced stages and iv) poorly understood mechanisms of tumor progression, metastasis and resistance to treatments and a consequent deficiency of targeted therapy. Therefore, understanding the molecular mechanisms of gastric cancer progression should be helpful to develop efficient treatments for the disease. Basic research should be emphasized to improve the clinical outcome of patients with gastric cancer.
B7-H3 is a member of the B7 immunoregulatory family. Previous studies have shown that the B7-H3 protein can be expressed in dendritic cells and the liver, lung, prostate as well as in some tumor cell lines (2) (3) (4) (5) . However, the physiological and pathological roles of B7-H3 are largely unknown. In an early study, human B7-H3 was reported as a co-stimulator of T cells, promoting T cell proliferation and cytokine production (6) . Subsequently, it was reported that in several mouse cancer models B7-H3 ectopic expression enhanced the induction of tumor-specific CD8 cytotoxic T cells, which may slow tumor growth or even completely eradicate tumors (7, 8) . More recently, B7-H3 was repeatedly implicated as a potent inhibitor of T cell activity (9) . Previous studies found that B7-H3-deficient mice showed airway inflammation (10), experimental autoimmune encephalitis (11) and allergic conjunctivitis in an accelerated pattern (12) . In contrast to these studies, Steinberger et al suggested that B7-H3 has no characteristics of a co-signaling molecule and it does not act as a regulator of immune response airway inflammation (3) . Therefore, the biological functions of B7-H3 are still unclear.
Metastasis, the spread of cancer cells from primary tumor sites to distant organs, is a complex process that involves induction of cell motility, activation of extracellular matrix proteases, intravasation to vessels, travel via the circulatory system and survival and establishment of secondary tumors in a new microenvironment (13, 14) . In addition, the process is the same in metastatic gastric cancer. It was recently suggested that B7-H3 is a tumor-associated antigen that regulates important cellular responses, such as adhesion and metastasis, which indicates its novel role in tumor progression (15) (16) (17) . In the present study, we focused on B7-H3 in gastric cancer tissues as well as in the human gastric cancer cell line SGC-7901.
Materials and methods
Reagents. The anti-human B7-H3 antibody was purchased from R&D Systems, inc. The horseradish peroxidase-conjugated secondary anti-mouse antibody was from Bio-Rad Laboratories, Inc. TRIzol reagent and MMLV were purchased from Gibco-BRL. Taq Dna polymerase, dnTPs and the Dna marker were purchased from Takara.
Patients. This study was approved by the Ethics Committee of The First People's Hospital of Wujiang for Clinical Investigation. Included in the study were 32 patients with gastric cancer who underwent radical resection operation. Patients were excluded from analysis if they received chemotherapy or radiation therapy before surgical operation or underwent previous gaster surgery. Specimens of gastric cancer were obtained following written consent, during surgical operation. At the same time, specimens of normal gastric tissues distant to the tumor were obtained as controls. The diagnosis of each tissue was confirmed using hematoxylin and eosin-stained sections. After dissection under sterile conditions, each tissue sample was collected, separated and divided into 2 groups during preparation and analysis. One group was fixed in 10% buffered methanol for immunohistochemical estimation of B7-H3 expression and another group was placed in a nitrogen canister and used for RNA extraction and RQ-PCR detection of B7-H3 expression.
Immunohistochemistry. Clinical specimens were used for immunohistochemical studies. Specimens were fixed in formalin overnight and embedded in paraffin. Series sections (4-µm) were prepared for immunohistological staining. Tissue sections were quenched for endogenous peroxidase with freshly prepared 3% H 2 O 2 with 0.1% sodium azide and then placed in an antigen retrieval solution for 15 min. After incubation in the casein block, primary antibodies such as anti-B7-H3 (1:50 dilution) were applied to the sections for 1 h at room temperature, followed by incubation with the secondary antibody and extravidin-conjugated horseradish peroxidase. The immune reaction was counterstained with hematoxylin, dehydrated and mounted. Sections were then evaluated for the presence of brown diaminobenzidine precipitates indicative of positive reactivity by microscopy. The brown staining in the cytoplasm was read as positive reactivity for B7-H3.
RNA extraction from tissue samples and real-time quantitative PCR (RQ-PCR) detection.
Total RNA was extracted from frozen gastric cancer and normal gastric tissue samples using the RNeasy ® Mini kit (Qiagen) following the manufacturer's instructions. The concentration and purity of the total RNA were detected with an ultraviolet spectrophotometer and then reversely transcribed into cDna using the QuantiTect ® reverse transcription kit. RQ-PCR assays were carried out using SYBR Green real-time PCR Master Mix and real-time PCR amplification equipment. GaPDH was used as an internal control. The PCR conditions consisted of 1 cycle at 95˚C for 15 sec followed by 45 cycles at 95˚C for 5 sec and at 60˚C for 30 sec. The primer sequences were as follows: 5'-CTCTGCCTTCTCaCCTCTTTG-3' (sense) and 5'-CCTTGaGGGaGGaaCTTTaTC-3' (antisense) for B7-H3 (134 bp); 5'-TGaCTTCaaCaGCGaCaCCCa-3' (sense) and 5'-CaCCCTGTTGCTGTaGCCaaa-3' (antisense) for GaPDH (121 bp).
Cells and cell culture. The gastric cancer cell line SGC-7901 was kindly provided by Jiangsu Provincial Institute of Hematology, China. SGC-7901 was cultured in Dulbecco's modified eagle's medium (Dmem; Lonza inc.), and all medium was supplemented with 10% fetal bovine serum (FBS; atlanta Biologicals inc.) and 1% penicillin-streptomycin (Gibco) at 37˚C under an atmosphere of 5% CO 2 . After the cells attained 80-90% confluency, they were harvested with 0.25% trypsin and split at a 1:3 ratio.
Generation of stable cell lines.
Small hairpin RNA (shRNA) of the human B7-H3 (GenBank, NM_001024736) lentivirus gene transfer vector encoding the green fluorescent protein (GFP) sequence was constructed by Shanghai GeneChem Co. (Shanghai, China). The targeting sequence of B7-H3 was 5'-GaGCaGGGCTTGTTTGaTGTG-3' and it was confirmed by sequencing. The recombinant lentivirus of small hairpin interference RNA targeting B7-H3 (LV-RNAi virus) and the non-targeted control mock lentivirus (LV-NC virus) were prepared and titered to 5x10 9 Tu/ml (transfection units). Cells were subcultured at 5x10 4 cells/well into 6-well tissue culture plates overnight. The viral supernatant was then added into the cells at a multiplicity of infection (mOi) of 10 with 5 µg/ml polybrene. GFP was evaluated by fluorescent microscopy to estimate the infection efficiency. The SGC-7901 cells infected were named as the LV-RNAi group and LV-NC group, respectively, and the SGC-7901 cells without infection were named as the control group. The three groups mentioned above were used in the experiments below. RQ-PCR was performed to confirm the knockdown of mRNA of B7-H3 in the transfectants using the same protocol mentioned above, and the RQ-PCR products were electrophoresed on 1.5% agarose gel containing 0.1% ethidium bromide. B7-H3 protein expression was analyzed by western blotting.
Western blotting. Cells were washed twice and lysed on ice. After centrifugation, the supernatant was collected. Protein concentrations were determined by the Bio-Rad DC protein assay system. Samples were then separated on 10% SDS-PaGe and transferred onto PVDF membranes. The membranes were blocked and incubated with the primary anti-bodies, anti-B7-H3 antibody (1:50 dilution) or anti-GaPDH antibody (1:100 dilution) at 4˚C overnight. after 3 washes, the membranes underwent hybridization with a goat anti-mouse IgG conjugated with horseradish peroxidase (1:500 dilution) for 2 h at room temperature. After further washing, the reactive bands were visualized using ECL™ western blot detection reagents with exposure to X-ray film for 30-120 sec. The band intensities were calculated by densitometric analysis using Image J software.
In vitro wound scrape assay. Cells of each group were incubated in 6-well plates. A small wound area was made in the confluent monolayer with a 200-µl pipette tip in a lengthwise stripe. Cells were then washed twice with PBS and incubated in serum-free Dmem at 37˚C in a 5% CO 2 incubator for 24 h (18, 19) . Images were captured at different times from 0 to 24 h. Wound width was measured at a x100 magnification using a BX50 microscope (Olympus, Tokyo, Japan) with a calibrated eyepiece grid (1 mm/100 µm graduation). Ten measurements were made at random intervals along the wound length. This experiment was conducted in triplicate.
In vitro invasion assay. A co-culture system was used as an alternative method to evaluate cancer cell invasiveness (20) . Briefly, the upper portion of Transwell inserts with an 8-µm pore size and a 6.5-mm diameter was coated with 20 µl matrigel diluted 1:3 in serum-free Dmem and incubated at 37˚C for 4 h. The coated inserts were placed in the well of a 24-well plate with 600 µl Dmem containing 10% FBS in the bottom chamber. After 12 h of serum starvation, the trypsinized cells were harvested and diluted to a 5x10 6 /ml cell suspension with serum-free Dmem. each cell suspension (100 µl) was added to the upper chambers. After incubation at 37˚C for 48 h in a 5% CO 2 atmosphere, the non-invading cells and gel were removed from the upper chamber with cottontipped swabs. The cells were rinsed with PBS, and cells on the filters were fixed with methanol for 30 min and stained with crystal violet solution (Sigma). The number of invading cells on the filters was counted in 5 random fields/filter at a x200 magnification in triplicate wells of each group.
Orthotopic transplantation gastric cancer model. BaLB/c-nu mice (5 weeks old), weighing 20-24 g, were anesthetized with a urethane (4 ml/kg) intramuscular injection. after the abdominal skin was sterilized, an incision was made in the upper left abdomen and the stomach was exposed. Orthotopic tumors were established by injecting 2x10 5 SGC-7901 cells subserously on the gastric wall in 20 µl of PBS, and the abdominal wall together with the skin was closed with silk sutures. The animals were allowed to recover for 24 h. Three groups of 6 surviving mice were bred in an aseptic specified pathogen-free (SPF) condition and maintained at a constant humidity and temperature (25-28˚C) . all of the mice were sacrificed 7 weeks after the orthotopic transplantation operation. Metastatic visceral tumors outside of the gastric wall, such as metastatic tumors in the liver, on the small intestine serous membrane surface or on the peritoneum, were excised carefully and weighed as described previously (17, 21) .
Statistical analysis. Gastric cancer and normal gaster tissue B7-H3 expression upon immunohistochemical staining was compared and assessed using the Chi-square test. Other data are shown as mean ± SD. Statistical comparisons were performed using the Student's t-test. all P-values were determined by two-sided tests with significance considered at <0.05. These analyses were performed using SPSS 13.0 software.
Results

Immunohistochemical staining and RQ-PCR of the patient tissue samples.
Immunohistochemical staining revealed significant overexpression of B7-H3 in the tumor tissues (Chi-square test 14.581; P<0.01). Positive staining for B7-H3 expression was detected in >50% of cells in 27 of the 32 gastric cancer specimens while no positive cells were detected in the normal gaster specimens (Fig. 1) . B7-H3 mRna expression in the clinic samples was detected by RQ-PCR. GaPDH was used as an internal control. Relative expression of the B7-H3 mRNA level was analyzed using the 2 -ΔΔCt method. The B7-H3 mRNA relative expression level in the gastric cancer group was significantly higher than that in the normal gaster group (mean 268±72 vs. 105±33; P<0.01; Fig. 2 ).
B7-H3 downregulation by RNA interference in the SGC-7901 cells.
After infection with the lentiviral vector, the SGC-7901 cells were examined by fluorescence microscopy (Fig. 3) . The results showed high efficiency of the lentiviral infection. To determine the efficiency of Rna interference, we analyzed the levels of B7-H3 mRNA and protein expression in the 3 groups. Fig. 4a and B shows B7-H3 mRna expression in the 3 groups. B7-H3 mRNA expression was obviously decreased in the LV-RNAi group when compared with level in the LV-NC or the control group (mean 20±13%, P<0.01) (Fig. 4B) . The inhibition rate was 80%. However, there was no significant difference between the LV-NC and the control group (P>0.05). A similar decrease was found in protein synthesis by western blotting (Fig. 4C) . These findings indicate that the downregulation of the B7-H3 gene by Rna interference was specific and efficient.
Migration on wound scrape assay in vitro.
To determine whether B7-H3 acts as a tumor migration regulator we used the wound scrape assay to evaluate cell motility. RNA interference resulting in inhibition of B7-H3 significantly decreased SGC-7901 cell migration in the wound scrape model (Fig. 5a) . Time course analysis of the wound closure showed that a monolayer was re-established within a significantly shorter period in the LV-NC and control groups than that in the LV-Rnai group (Fig. 5B) .
Invasion ability on Transwell assay in vitro.
After downregulation of the expression of B7-H3 by RNA interference, an in vitro assay on matrigel filters revealed that the number of invading SGC-7901 cells was decreased up to 50% (P<0.05, LV-Rnai group vs. the control group) (Fig. 6a and B) . There was no statistical significance in the number of invading cells between the LV-NC and the control group (P>0.05). 
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Metastatic tumors in the orthotopic transplantation gastric cancer mouse model. All of the 18 mice were sacrificed 7 weeks after the transplantation operation. All of the mice developed orthotopic transplantation gastric cancer tumors in this experiment. Abdominal visceral metastatic tumors were detected, excised and weighed (Fig. 7a) . The number of cases of liver metastasis in the LV-Rnai group (0/6, 0%) was less than the number in the LV-nC group (5/6, 83.33%) or the control group (6/6, 100%). The effect of inhibiting metastasis by knockdown of B7-H3 was assessed in terms of the average postmortem abdominal visceral metastatic tumor weight. Inhibition of metastasis was observed in the LV-RNAi group, when compared to the LV-NC group (2.02±0.74 g) or the control group (2.30±0.55 g). The average weight of the 
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abdominal visceral metastatic tumors (0.82±0.39 g) in the former group was significantly lower than that in the LV-nC and control groups ( Fig. 7B; P<0 .01). There was no statistical significance in the metastatic visceral tumor weight between the LV-NC and the control group (P>0.05). These results indicated that inhibition of B7-H3 expression reduced gastric cancer metastasis in vivo. It strongly support the effects observed in vitro indicating that B7-H3 plays a vital role in invasion and migration of gastric cancer cells.
Discussion
In addition to the traditional B7-1 and B7-2 family members, other B7-CD28 family members have been discovered, including B7-H1 (22), B7-H2 (23), B7-H3 (6), B7-H4 (24), B7-DC (25) and B7-H6 (26) . among these, B7-H3 is a currently controversial co-stimulatory molecule, which plays crucial roles after initial antigen priming in cooperation with a putative counter-receptor. Recently, increasing evidence indicates that B7-H3 plays an important role in tumor progression. Wu et al reported that B7-H3 expression is related to survival time and tumor infiltration depth in gastric cancer cases (27) . Zhang et al found that circulating B7-H3 in serum is a highly sensitive biomarker for non-small cell lung cancer (NSCLC), and increased circulating B7-H3 suggests a poor clinical prognosis for NSCLC (28) . Sun et al reported that in the NSCLC environment the B7-H3 signaling pathway may be involved in switching macrophages to the M2 phenotype and the negative regula tion of the T lymphocyte-mediated immune response, thus they hypothesized that B7-H3 is important in NSCLC progression (29) . Qin et al found that the specific expression of B7-H3 in tumors and tumor vasculature in clear cell renal cell carcinoma makes it a useful target and prominent biomarker for tumor-specific antiangiogenic therapies. They concluded that B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma (30) . Yamato et al found that B7-H3 expression was significantly more intense in cases with lymph node metastasis and advanced pathological stage in pancreatic cancer (5) . B7-H3 aberrant expression also reportedly correlates with tumor aggressiveness and poor clinical outcome, suggesting that B7-H3 has a critical role in tumor cell progression.
In the present study, we also found that B7-H3 was overexpressed in gastric cancer when compared with the expression level in normal gaster tissues by immunohistochemical staining. Since we realized the limitation of using immunohistochemical methods for semi-quantitative analysis, we also used RQ-PCR. Our results showed aberrant B7-H3 expression in gastric cancer, in accord with the findings of Wu et al (27) . However, why does B7-H3 overexpression correlate with pathological indicators of aggressive cancer and clinical outcome? Does it have effects on tumor metastasis? To further investigate whether B7-H3 contributes to tumor metastasis, we performed a wound scrape assay to evaluate cell motility and a Transwell invasion assay to assess cell invasiveness in vitro in order to determine the mechanisms of cell metastasis toward distant tissues. The results revealed that B7-H3 has a putatively important role in tumor migration and invasiveness, indicating higher aggressiveness and a poor clinical outcome. In addition, the results in vitro were confirmed in our studies in vivo. In the orthotopic transplantation gastric cancer model, we found that decreased B7-H3 expression reduced tumor metastasis. Compared to the control group, there was a marked reduction in the LV-RNAi group in regards to the weight of the abdominal visceral metastatic tumors and in the liver metastasis rate. 
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Carcinogenesis is a multiple step process in which cancer cells lose proliferation control, disseminate from a localized primary tumor mass to invading adnexa and metastasize to distant organs (31) . Our study suggests that B7-H3 may play a vital role in gastric cancer metastasis. However, whether B7-H3 regulates cancer metastasis directly or through some important intracellular pathways, still requires investigation and we will engage in this field further. Furthermore, the underlying mechanisms concerning how cancer cells aberrantly upregulate B7-H3 expression are still unknown and are under research. Zhao et al repoted that B7-H3 is probably a direct target of microRNA-187. Overexpression of miR-187 decreased the B7-H3 mRNA level and repressed B7-H3-3'-UTR reporter activity (32) . We will also further study the internal mechanisms of regulation of B7-H3 expression in gastric cancer cells.
In summary, our study investigating the role of B7-H3 in gastric cancer metastasis revealed that B7-H3 promotes cancer cell migration and invasiveness in vitro and in vivo. Furthermore, in contrast to previous reports focusing on the immunoregulatory effects of B7-H3, which are involved in evasion of cancer immune surveillance, our data demonstrate that it plays a critical role in gastric cancer metastasis such as migration and invasiveness via non-immunomechanisms. These findings provide new insight into the role of B7-H3 in gastric cancer and may have important implications in the development of targeted therapeutics for the disease.
